Review
doi: 10.1111/j.1445-5994.1998.tb01976.x.
The role of ifosfamide in paediatric cancer
Affiliations
- PMID: 9673760
- DOI: 10.1111/j.1445-5994.1998.tb01976.x
Item in Clipboard
Review
The role of ifosfamide in paediatric cancer
Aust N Z J Med.
1998 Jun.
Abstract
Ifosfamide is an active drug in the therapy of paediatric tumours such as rhabdomyosarcoma, Ewings' sarcoma, Wilms' tumour, neuroblastoma, germ cell tumours and lymphomas. Myelosuppression is the major toxicity along with haemorrhagic cystitis. The latter is largely prevented by the use of concomitant mesna.
Similar articles
-
Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.Semin Oncol. 1996 Jun;23(3 Suppl 6):84-90. Semin Oncol. 1996. PMID: 8677456 Review.
-
Ifosfamide in the treatment of soft tissue sarcomas.Semin Oncol. 1996 Jun;23(3 Suppl 6):16-21. Semin Oncol. 1996. PMID: 8677442 Review.
-
Ifosfamide in pediatric solid tumors.Oncology. 2003;65 Suppl 2:99-104. doi: 10.1159/000073369. Oncology. 2003. PMID: 14586158 Review.
-
Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.Am J Clin Oncol. 1995 Dec;18(6):498-501. doi: 10.1097/00000421-199512000-00009. Am J Clin Oncol. 1995. PMID: 8526193 Clinical Trial.
-
Ifosfamide in pediatric malignant solid tumors.Cancer Chemother Pharmacol. 1989;24 Suppl 1:S24-7. doi: 10.1007/BF00253234. Cancer Chemother Pharmacol. 1989. PMID: 2503257
Cited by
-
Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy.Cancers (Basel). 2024 Sep 10;16(18):3123. doi: 10.3390/cancers16183123. Cancers (Basel). 2024. PMID: 39335095 Free PMC article. Review.
-
Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis.FASEB J. 2018 Aug;32(8):4408-4419. doi: 10.1096/fj.201701415R. Epub 2018 Apr 3. FASEB J. 2018. PMID: 29613835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources